This is an Open-label, Single Arm Study to Evaluate the Safety and Tolerability of Treatment With CT0591CP in Patients With Relapsed and/or Refractory Multiple Myeloma.

NCT05486975 · clinicaltrials.gov ↗
EARLY_PHASE1
Phase
UNKNOWN
Status
18
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

The First Affiliated Hospital of Soochow University